Trevena Inc (TRVN) Wednesday reported fourth-quarter losses that were wider than analysts’ estimates, sending its shares down 5.4% during pre-market trading. Helped by substantially lower research and development expenses during the quarter, net loss narrowed to 10 cents per share from 24 cents per share a year ago.
However, this wasn’t good enough for the street, which was expecting a loss of only 6 cents per share.

Q4 revenue of the clinical-stage biopharmaceutical company stood at $232 million, surpassing analysts’ estimate.
TRVN shares have slipped 23% in the trailing 52 weeks. Meanwhile, it has gained 16% since the beginning of this year.
Trevena announced that it has identified a new candidate for its S1P receptor program, designated as TRV045, which holds promise as a new mechanism for non-opioid treatment of chronic pain and other central nervous system disorders.
CEO Carrie Bourdow said, “We have achieved meaningful milestones with our early-stage pipeline assets and, in 2019, expect to continue the development of these assets to build long-term stockholder value.”
On Tuesday, shares of Cara Therapeutics (CARA) surged about 10% during the extended trading hours, after reporting better-than-expected results in the fourth quarter. Viking Therapeutics (VKTX) is scheduled to report quarterly results after the closing bell today.
Earnings Calendar: Browse through our earnings calendar and get all scheduled earnings announcements, analyst/investor conference and much more!
Most Popular
Infographic: Key highlights from Kohl’s Corporation’s (KSS) Q1 2022 earnings results
Kohl’s Corporation (NYSE: KSS) reported first quarter 2022 earnings results today. Total revenue decreased 4.4% year-over-year to $3.7 billion. Reported net income amounted to $14 million, or $0.11 per share,
Foot Locker (FL) bets on diversification to maintain sales. Is the stock a buy?
Foot Locker, Inc. (NYSE: FL) is a highly sought-after sportswear retailer, offering a wide range of products including sneakers and athletic apparel. Like most traditional store operators, the company is
Cisco (CSCO) Earnings: Q3 2022 profit beats estimates
Cisco Systems Inc. (NASDAQ: CSCO) published third-quarter results Wednesday after the closing bell, reporting higher earnings and flat revenues. Third-quarter adjusted earnings rose to $0.87 per share from $0.83 per